On June 5, 2025, Portage Biotech Inc. issued 625,000 shares for $5 million to Compedica, resulting in Compedica owning 27.4% of Portage post-transaction, aimed at supporting the development of Compedica's medical device.
AI Assistant
ALPHA COMPUTE CORP
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.